
News|Videos|November 13, 2023
Case 1: A 55-Year-Old Female
Advertisement
Patient Care Online® “ConsultantLive™” program titled “Treatment Considerations for patients with Decompensated Cirrhosis and Hepatic Encephalopathy”.
Panelists:
Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
Pfleger Liver Institute/David Geffen School of Medicine UCLA
Los Angeles, California
Program Description:
In this video series, an expert in the management of liver conditions provides an overview of cirrhosis, including its epidemiology and the distinction between compensated and decompensated forms. Patient cases are reviewed to highlight hepatic encephalopathy as a complication and how to manage and prevent the recurrence of this condition.
Advertisement
Related to this article

Ascletis submits an FDA IND for ASC30_39, an oral GLP-1–amylin obesity combination supported by preclinical data.

AHA 2026: Yoga-based cardiac rehabilitation improved quality of life and walking distance in patients with HFrEF but did not significantly reduce death, hospitalization, or stroke.

The ACS 2026 prostate cancer screening guidelines recommend risk-based PSA testing beginning at age 45 or 50, with updated follow-up thresholds.

Retatrutide trials report less knee osteoarthritis pain; ixekizumab plus tirzepatide shows exploratory ACR50 benefits in psoriatic arthritis.

Asundexian reduced relative ischemic stroke risk by 26% alongside antiplatelet therapy, with bleeding concerns in older adults.

Survodutide demonstrated cardiovascular safety vs placebo in the phase 3 SYNCHRONIZE-CVOT trial, with improvements in weight and cardiometabolic risk factors.

Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Advertisement
Advertisement
Trending on Patient Care Online
1
Ascletis Submits FDA IND for ASC30_39 Oral Obesity Combination
2
Comparing VMS Therapy Effects on Menopausal Sleep
3
American Cancer Society Updates Prostate Cancer Screening Guidelines
4
Individualizing Treatment for Menopausal Sleep Disturbances
5






